MBC Agenda. CALDA Lorraine Johnson, JD, MBA 10 min Executive Director of CALDA Two standards of care From emerging practices to mainstream Specialty bias position statement ILADS Dr. Raphael Stricker, M.D. 10 min Dr. Steven Harris, M.D.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Executive Director of CALDA
Dr. Steven Harris, M.D.
For additional information contact Lorraine Johnson at 323-461-6184.
Considerable specialty bias exists in the treatment of Lyme disease. A diagnosis or treatment approach under one standard of care is frequently repudiated by physicians following the other standard of care.
This appears to be a highly polarized and politicized conflict, as was demonstrated to this Committee by expert testimony from both sides, each supported by numerous medical journal articles, and each emphatic that the opposing position was clearly incorrect… What clearly did emerge however, was that Respondent’s approach, while certainly a minority viewpoint, is one that is shared by many other physicians. … We are also acutely aware that it was not this Committee’s role to resolve this medical debate…
The issues raised in this case pertained primarily to the medical debate in this field, rather than a demonstrated lack of competency by the Respondent.
Outliers are “low hanging fruit” easy to spot and target.
A sicker population group means more adverse events
Insurers target expensive care
Investigators may be unaware that different treatment approaches exist.
Physicians may be unaware or may disagree with treatment approach.Non-Mainstream Treatments Are More Likely to be Targets for MBC Action